The collaboration centers on colorectal cancer screening, surveillance and diagnostics. The new agreement focuses on Exact Sciences’ relationship with Mayo Clinic gastroenterologist and co-inventor of Cologuard David Ahlquist, MD.
“This unique collaboration is producing powerful results,” said John Noseworthy, MD, president and CEO of Mayo Clinic. “The success of our teams in developing Cologuard exemplifies what can happen when two organizations combine their expertise and unite toward a single goal.”
The original agreement dates back to June 11, 2009.
More articles on gastroenterology:
HCV outbreak confirmed at Tri-City Colonoscopy Clinic in Canada
6 gastroenterologists serving as CMOs
New drugs, screening tactics could nearly eliminate HCV by 2036
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.